Miguel Seabra

Company: Champalimaud Foundation

Job title: Professor

Seminars:

mRNA & Gene Editing – Delineating the Convergence of mRNA’s Potential as a Tool to Treat Genetic Diseases 12:45 pm

With the UK approval of the world’s first gene-editing treatment for blood cancer, the race is now on to develop next-generation gene editing technologies leveraging mRNA technology with the mission to develop curative therapies for some of the most challenging genetic diseases. With a convergence of academic and industry collaborations to focus on bringing these…Read more

day: mRNA Technology & Innovation Day